We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
AVLN icon
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB icon
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RPRX icon
26
Royalty Pharma
RPRX
$25.2B
$77.7M 1.04%
1,380,261
+67,727
+5% +$3.53M
2022 Q4
14 quarters
AXSM icon
27
Axsome Therapeutics
AXSM
$8.22B
$77.5M 1.04%
316,820
-202,738
-39% -$44M
2023 Q3
11 quarters
TER icon
28
Teradyne
TER
$58.3B
$71.4M 0.95%
147,984
+20,518
+16% +$7.74M
2025 Q4
2 quarters
DHI icon
29
D.R. Horton
DHI
$37.8B
$71.1M 0.95%
436,562
+5,691
+1% +$849K
2019 Q4
26 quarters
TOST icon
30
Toast
TOST
$17.8B
$69.4M 0.93%
2,494,706
+6,037
+0.2% +$157K
2023 Q2
12 quarters
PWR icon
31
Quanta Services
PWR
$102B
$67.1M 0.9%
93,231
+3,845
+4% +$2.63M
2024 Q2
8 quarters
WMB icon
32
Williams Companies
WMB
$90.5B
$66.9M 0.89%
898,241
+65,993
+8% +$4.86M
2021 Q4
18 quarters
MTD icon
33
Mettler-Toledo International
MTD
$31.7B
$66.5M 0.89%
52,116
+1,365
+3% +$1.65M
2018 Q2
32 quarters
INSM icon
34
Insmed
INSM
$21.2B
$62.2M 0.83%
583,665
+37,355
+7% +$4.52M
2022 Q4
14 quarters
RBA icon
35
RB Global
RBA
$16.4B
$61.5M 0.82%
528,645
+502
+0.1% +$52.8K
2024 Q4
6 quarters
LBRT icon
36
Liberty Energy
LBRT
$3.09B
$60.6M 0.81%
2,314,729
-88,369
-4% -$2.64M
2025 Q4
2 quarters
BLTE icon
37
Belite Bio
BLTE
$6.23B
$60.2M 0.8%
390,829
+33,179
+9% +$5.09M
2025 Q3
3 quarters
DTM icon
38
DT Midstream
DTM
$12.8B
$59.8M 0.8%
407,626
+5,675
+1% +$803K
2024 Q4
6 quarters
KYMR icon
39
Kymera Therapeutics
KYMR
$8.96B
$57.8M 0.77%
504,210
-122,715
-20% -$10.5M
2024 Q1
9 quarters
NDAQ icon
40
Nasdaq
NDAQ
$52.4B
$55.9M 0.75%
711,213
-626
-0.1% -$54.9K
2024 Q3
7 quarters
SITM icon
41
SiTime
SITM
$16.9B
$55.1M 0.74%
74,014
+349
+0.5% +$220K
2024 Q3
7 quarters
NI icon
42
NiSource
NI
$19.8B
$55.1M 0.74%
1,158,290
+14,700
+1% +$696K
2024 Q4
6 quarters
ESI icon
43
Element Solutions
ESI
$8.89B
$54.7M 0.73%
1,149,055
-22,412
-2% -$930K
2021 Q3
19 quarters
NVDA icon
44
NVIDIA
NVDA
$5.49T
$54.4M 0.73%
273,735
+14,316
+6% +$2.94M
2022 Q4
14 quarters
ABVX icon
45
Abivax
ABVX
$7.45B
$52.6M 0.7%
394,957
+74,381
+23% +$8.42M
2025 Q3
3 quarters
VMC icon
46
Vulcan Materials
VMC
$31.7B
$50.1M 0.67%
169,825
+253
+0.1% +$72.5K
2025 Q1
5 quarters
ORLY icon
47
O'Reilly Automotive
ORLY
$69.9B
$50M 0.67%
544,082
+4,202
+0.8% +$383K
2022 Q4
14 quarters
TRVI icon
48
Trevi Therapeutics
TRVI
$1.78B
$49.6M 0.66%
2,660,000
+37,694
+1% +$548K
2025 Q2
4 quarters
COLL icon
49
Collegium Pharmaceutical
COLL
$706M
$49.3M 0.66%
1,361,228
-63,054
-4% -$2.15M
2015 Q2
44 quarters
EGP icon
50
EastGroup Properties
EGP
$10.6B
$48.9M 0.65%
241,049
+5,319
+2% +$1.07M
2021 Q4
18 quarters
1
2
3 4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.